Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (861-870 of 881) with videos related to

Pageof 89
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid MalignanciesMarcelo C Pasquini, Mei-Jie Zhang, Bruno C Medeiros, et al.
Current Oncology (Toronto, Ont.)|December 31, 2020
Pre-Transplant Marital Status and Hematopoietic Cell Transplantation OutcomesJ Tay, S Beattie, C Bredeson, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 6, 2018
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell TransplantationMaxim Norkin, Bronwen E Shaw, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Blood Advances|May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisRoni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantationMehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Blood Advances|May 13, 2020
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseasesJustine M Kahn, Ruta Brazauskas, Heather R Tecca, et al.
Pageof 89

Showing results (861-870 of 881) with videos related to

Sort By:
Pageof 89
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid MalignanciesMarcelo C Pasquini, Mei-Jie Zhang, Bruno C Medeiros, et al.
Current Oncology (Toronto, Ont.)|December 31, 2020
Pre-Transplant Marital Status and Hematopoietic Cell Transplantation OutcomesJ Tay, S Beattie, C Bredeson, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 6, 2018
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell TransplantationMaxim Norkin, Bronwen E Shaw, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Blood Advances|May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisRoni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantationMehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Blood Advances|May 13, 2020
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseasesJustine M Kahn, Ruta Brazauskas, Heather R Tecca, et al.
Pageof 89